Eli Lilly and Company (LLY)

Index:

S&P 100

$ 925.81
   
  • Change Today:
    $18.95
  • 52 Week High: $955.46
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 7,229,375
  • Market Cap: $877,825m
  • RiskGrade: 179
  • Beta: 0.69

Latest ShareCast News

Eli Lilly posts stronger-than-expected Q3 earnings

By Iain Gilbert

Date: Thursday 30 Oct 2025

(Sharecast News) - Pharmaceutical giant Eli Lilly posted stronger-than-expected third-quarter earnings and revenue on Thursday, fuelled by surging demand for its diabetes drug Mounjaro and weight-loss treatment Zepbound.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 925.81
Change Today $ 18.95
% Change 2.09 %
52 Week High $955.46
52 Week Low $625.65
Volume 7,229,375
Shares Issued 948.17m
Market Cap $877,825m
Beta 0.69
RiskGrade 179

What The Brokers Say

Strong Buy 11
Buy 11
Neutral 8
Sell 0
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page